InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,235.48
(
-0.60%
)
US TECH 100
18,018.00
(
-1.31%
)
Dow Jones
38,111.48
(
-0.86%
)
Brent Oil
81.96
(
-1.70%
)
Bitcoin
68,350.82
(
1.12%
)
Post# of 424697
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Anonymous Fish

Send PM Follow Ignore
Followers 8
Posts 288
Boards Moderated 0
Alias Born 11/12/2018

Anonymous Fish

Re: None

Monday, 11/18/2019 4:07:21 PM

Monday, November 18, 2019 4:07:21 PM

Post# of 424697
What are the chances of the FDA issuing a CRL requesting that Amarin conduct a pharmacokinetic type study to observe the effects of the mineral oil placebo on statin absorption before resubmitting the NDA? And if they did that, and it delayed approval, would it not be very convenient for AZN while they await the results of their outcome study, and also the FDA who would then have two sets of outcome data from the same class of drug to compare?

Anyone else notice the two gaps down to 21.49 and 16.91? Hmmmmmmmm.

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

FEATURED Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • May 30, 2024 1:18 PM

Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM

ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM

North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM

One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM

Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!